- Home
- VCEL vs ESTA Comparison
VCEL vs ESTA Comparison
Compare VCEL & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | ESTA |
|---|---|---|
| Founded | 1989 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VCEL | ESTA |
|---|---|---|
| Price | $36.30 | $74.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $57.75 | ★ $86.86 |
| AVG Volume (30 Days) | ★ 588.4K | 387.1K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | 42.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $276,259,000.00 | $61,208,000.00 |
| Revenue This Year | $19.40 | $28.05 |
| Revenue Next Year | $18.24 | $26.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 16.45 | ★ 76.49 |
| 52 Week Low | $28.95 | $33.35 |
| 52 Week High | $45.97 | $83.31 |
Technical Indicators
Market Signals| Indicator | VCEL | ESTA |
|---|---|---|
| Relative Strength Index (RSI) | 58.19 | 57.97 |
| Support Level | $35.85 | $63.47 |
| Resistance Level | $38.31 | $75.61 |
| Average True Range (ATR) | 1.57 | 4.02 |
| MACD | 0.16 | 0.31 |
| Stochastic Oscillator | 81.12 | 67.51 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.